Moreno is a 24-year-old from Los Angeles, California; her ideal neon sign is “You’ll Have Fun.”
View this post on InstagramShe is a self-proclaimed Dominicana whose first language is Spanish. She explained that her mom is her best friend: “She's the reason I'm bubbling.”
She explained that she sees her friends as her sisters. “I don't use the term girl's girl. Any real woman who loves women never has to say I'm a girl's girl. It just shows on the way you behave and the way you show up for them.”
Moreno shared she loves to cook for her man and described herself as old-fashioned, but added that she was a Scorpio and “we’re a little freaky,” while adding that sex is Important to her and “it has to be good.”
View this post on InstagramFans quickly showed their support for Moreno in the comment section on Instagram. One user wrote, "I love that she isn’t a girls girl because any real woman that loves women doesn’t have to preach that she is a girls girl, and she reminds me of someone who isn’t afraid to step on toes. I love her energy, and so far she’s one of my top favorites this season."
With a third user sharing, "I like her! She seems genuine and down to earth! Hope the guys in the villa are good enough for her"
Love Island USA begins June 2, 2026, streaming exclusively on Peacock.
Hence then, the article about i don t use that term this new love island usa islander calls out a major reality tv cliche was published today ( ) and is available on Parade ( Saudi Arabia ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( ‘I Don't Use That Term’: This New ‘Love Island USA’ Islander Calls Out a Major Reality TV Cliché )
Also on site :
- Berkshire Hathaway to Acquire Taylor Morrison Home Corporation for $8.5 Billion
- 2026 ASCO .. Innovent Presents Preliminary PoC Data of IBI363 (TAK-928) PD-1/IL-2α-bias bispecific fusion protein) in First-line Advanced NSCLC
- D3 Bio Presents First-Line Data for Elisrasib (D3S-001) at ASCO 2026; Next-Generation KRAS G12C Inhibitor Shows Landmark Efficacy in Untreated NSCLC